Outcome of Emicizumab prophylaxis in twins with severe hemophilia A and inhibitors.
preprint
OA: closed
Abstract
We describe the initial results of Emicizumab prophylaxis in twins diagnosed with severe Hemophilia A and inhibitors with intron 22 inversion. Prophylaxis was initiated in both the twins showing high annual bleed rate and difficult venous access. The treatment resulted in zero spontaneous bleeds and there were no adverse events.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00